Improving treatments for injuries caused by mustard gas exposure
Translation & trials: advancing medical countermeasure development
This study is looking into how mustard gas can seriously hurt the skin and other tissues, and it's for anyone interested in understanding how our immune system responds to these injuries so we can find better ways to help people heal.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10907618 on NIH RePORTER |
What this research studies
This research investigates the severe injuries caused by mustard gas and related compounds, focusing on the complex immune responses that occur after exposure. The team aims to understand how these injuries affect both the skin and deeper tissues, utilizing human and animal tissue samples to study the immune system's role in the healing process. By analyzing skin explants and immune cell interactions, the researchers hope to identify effective countermeasures that can mitigate the harmful effects of mustard exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to mustard gas or similar alkylating agents and are experiencing related skin and tissue injuries.
Not a fit: Patients who have not been exposed to mustard gas or do not exhibit symptoms related to such exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients suffering from injuries caused by mustard gas, enhancing recovery and reducing long-term complications.
How similar studies have performed: Previous research has shown promise in using immune modulation strategies to treat similar injuries, indicating that this approach may yield beneficial results.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Lu, Kurt — Northwestern University at Chicago
- Study coordinator: Lu, Kurt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.